POSA148 Cost Effectiveness of Ofatumumab in Comparison with Other Disease Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada
- Resource Type
- Abstract
- Source
- In
Value in Health January 2022 25(1) Supplement:S63-S63 - Subject
- Language
- ISSN
- 1098-3015